Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin

Fang Liz Zhou, Lin Xie, Chunshen Pan, Yuexi Wang, Neel Vaidya, Fen Ye, Ronald Preblick, Luigi Meneghini

Research output: Contribution to journalArticle

Abstract

This study examines the relationship between glycated haemoglobin (A1C) levels and treatment persistence with, or time to discontinuation of, basal insulin in patients with type 2 diabetes (T2D) newly initiating insulin. Claims data were extracted from the Optum Clinformatics database from January 2010 to June 2015. Adult patients with T2D initiating insulin glargine 100U/mL (Gla-100) or insulin detemir (DET) with ≥1 A1C measurement during 12-month baseline and 18-month follow-up periods were included. Patients with a refill gap of >90days were considered non-persistent; otherwise, patients were considered persistent with insulin. The main outcome was A1C, measured closest to the end of each quarter during the follow-up period. A total of 3993 of 109934 patients met the inclusion criteria (43.0% persistent; 57.0% non-persistent). Persistent patients were older (54.7 vs 52.7 years; P <.001), were more likely to be male (59.4% vs 54.4%; P =.002), and had significantly lower mean unadjusted A1C values at 18months (8.26% vs 8.60%; P <.001) and quarterly. Only 43.0% of adults initiating basal insulin persisted with treatment for 18months, with earlier discontinuation associated with higher A1C.

Original languageEnglish (US)
JournalDiabetes, Obesity and Metabolism
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Type 2 Diabetes Mellitus
Insulin
Therapeutics
Glycosylated Hemoglobin A
Databases

Keywords

  • Basal insulin
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin. / Zhou, Fang Liz; Xie, Lin; Pan, Chunshen; Wang, Yuexi; Vaidya, Neel; Ye, Fen; Preblick, Ronald; Meneghini, Luigi.

In: Diabetes, Obesity and Metabolism, 01.01.2018.

Research output: Contribution to journalArticle

@article{eeb7d305baa64d1c92d6870f4203d26f,
title = "Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin",
abstract = "This study examines the relationship between glycated haemoglobin (A1C) levels and treatment persistence with, or time to discontinuation of, basal insulin in patients with type 2 diabetes (T2D) newly initiating insulin. Claims data were extracted from the Optum Clinformatics database from January 2010 to June 2015. Adult patients with T2D initiating insulin glargine 100U/mL (Gla-100) or insulin detemir (DET) with ≥1 A1C measurement during 12-month baseline and 18-month follow-up periods were included. Patients with a refill gap of >90days were considered non-persistent; otherwise, patients were considered persistent with insulin. The main outcome was A1C, measured closest to the end of each quarter during the follow-up period. A total of 3993 of 109934 patients met the inclusion criteria (43.0{\%} persistent; 57.0{\%} non-persistent). Persistent patients were older (54.7 vs 52.7 years; P <.001), were more likely to be male (59.4{\%} vs 54.4{\%}; P =.002), and had significantly lower mean unadjusted A1C values at 18months (8.26{\%} vs 8.60{\%}; P <.001) and quarterly. Only 43.0{\%} of adults initiating basal insulin persisted with treatment for 18months, with earlier discontinuation associated with higher A1C.",
keywords = "Basal insulin, Type 2 diabetes",
author = "Zhou, {Fang Liz} and Lin Xie and Chunshen Pan and Yuexi Wang and Neel Vaidya and Fen Ye and Ronald Preblick and Luigi Meneghini",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/dom.13200",
language = "English (US)",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin

AU - Zhou, Fang Liz

AU - Xie, Lin

AU - Pan, Chunshen

AU - Wang, Yuexi

AU - Vaidya, Neel

AU - Ye, Fen

AU - Preblick, Ronald

AU - Meneghini, Luigi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This study examines the relationship between glycated haemoglobin (A1C) levels and treatment persistence with, or time to discontinuation of, basal insulin in patients with type 2 diabetes (T2D) newly initiating insulin. Claims data were extracted from the Optum Clinformatics database from January 2010 to June 2015. Adult patients with T2D initiating insulin glargine 100U/mL (Gla-100) or insulin detemir (DET) with ≥1 A1C measurement during 12-month baseline and 18-month follow-up periods were included. Patients with a refill gap of >90days were considered non-persistent; otherwise, patients were considered persistent with insulin. The main outcome was A1C, measured closest to the end of each quarter during the follow-up period. A total of 3993 of 109934 patients met the inclusion criteria (43.0% persistent; 57.0% non-persistent). Persistent patients were older (54.7 vs 52.7 years; P <.001), were more likely to be male (59.4% vs 54.4%; P =.002), and had significantly lower mean unadjusted A1C values at 18months (8.26% vs 8.60%; P <.001) and quarterly. Only 43.0% of adults initiating basal insulin persisted with treatment for 18months, with earlier discontinuation associated with higher A1C.

AB - This study examines the relationship between glycated haemoglobin (A1C) levels and treatment persistence with, or time to discontinuation of, basal insulin in patients with type 2 diabetes (T2D) newly initiating insulin. Claims data were extracted from the Optum Clinformatics database from January 2010 to June 2015. Adult patients with T2D initiating insulin glargine 100U/mL (Gla-100) or insulin detemir (DET) with ≥1 A1C measurement during 12-month baseline and 18-month follow-up periods were included. Patients with a refill gap of >90days were considered non-persistent; otherwise, patients were considered persistent with insulin. The main outcome was A1C, measured closest to the end of each quarter during the follow-up period. A total of 3993 of 109934 patients met the inclusion criteria (43.0% persistent; 57.0% non-persistent). Persistent patients were older (54.7 vs 52.7 years; P <.001), were more likely to be male (59.4% vs 54.4%; P =.002), and had significantly lower mean unadjusted A1C values at 18months (8.26% vs 8.60%; P <.001) and quarterly. Only 43.0% of adults initiating basal insulin persisted with treatment for 18months, with earlier discontinuation associated with higher A1C.

KW - Basal insulin

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85041073080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041073080&partnerID=8YFLogxK

U2 - 10.1111/dom.13200

DO - 10.1111/dom.13200

M3 - Article

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

ER -